None listed
Conditions
Brief summary
The study consisted of 2 groups. 25 mcg vaginal misprostol was applied to the patients in the intervention group for labor induction. Patients in the control group were followed up spontaneously. The results of both groups were compared.
Interventions
Since misoprostol is only indicated for postterm pregnant women for labor induction in our country, 25 mcg misoprostol was administered vaginally to women with a singleton pregnancy in vertex presentation, without previous uterine surgery, with a pregnancy of 42 weeks or more, and with a Bishop score of five and/or below. In patients with no response, the repeat dose was repeated a maximum of four times. Misoprostol was not administered to patients who did not want to receive labor induction or who went into spontaneous labor. Misoprostol was administered by a gynecologist and obstetrician. After the patients were administered misoprostol, NST was monitored continuously for the first two hours and at two-hour intervals in the following period. After the application, all data such as the patients' delivery times, delivery methods, cesarean delivery indications, and induction dose numbers were recorded by the gynecologist.
Sponsors
Study design
Eligibility
Inclusion criteria
singleton pregnancy fetus in cephalic presentation participants who consented to the study
Exclusion criteria
multiple pregnancy presence of uterine surgery malpresentation placenta previa asthma glaucoma disagreement to participate in the study